Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

NCT02779348 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIA 3-202
DRUG: warfarin

Sponsor

Bial - Portela C S.A.